ES549873A0 - 1,4-dihidropiridin-carboxiamidas. - Google Patents

1,4-dihidropiridin-carboxiamidas.

Info

Publication number
ES549873A0
ES549873A0 ES549873A ES549873A ES549873A0 ES 549873 A0 ES549873 A0 ES 549873A0 ES 549873 A ES549873 A ES 549873A ES 549873 A ES549873 A ES 549873A ES 549873 A0 ES549873 A0 ES 549873A0
Authority
ES
Spain
Prior art keywords
dihidropiridin
carboxiamidas
dihyropyridinecarboxamides
thromboembolisms
ischaemias
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549873A
Other languages
English (en)
Other versions
ES8700850A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8700850A1 publication Critical patent/ES8700850A1/es
Publication of ES549873A0 publication Critical patent/ES549873A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
ES549873A 1984-12-15 1985-12-12 1,4-dihidropiridin-carboxiamidas. Expired ES8700850A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445852 DE3445852A1 (de) 1984-12-15 1984-12-15 Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES8700850A1 ES8700850A1 (es) 1986-11-16
ES549873A0 true ES549873A0 (es) 1986-11-16

Family

ID=6252899

Family Applications (4)

Application Number Title Priority Date Filing Date
ES549873A Expired ES8700850A1 (es) 1984-12-15 1985-12-12 1,4-dihidropiridin-carboxiamidas.
ES556986A Expired ES8801207A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES556987A Expired ES8707501A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES556988A Expired ES8801208A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4 dihidropiridincarboxiamidas

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES556986A Expired ES8801207A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES556987A Expired ES8707501A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4-dihidropiridincarboxiamidas
ES556988A Expired ES8801208A1 (es) 1984-12-15 1986-08-01 Procedimiento para la obtencion de 1,4 dihidropiridincarboxiamidas

Country Status (11)

Country Link
US (1) US4707479A (es)
EP (1) EP0185964B1 (es)
JP (1) JPH0631224B2 (es)
AT (1) ATE50571T1 (es)
AU (1) AU5107085A (es)
CA (1) CA1259996A (es)
DE (2) DE3445852A1 (es)
DK (1) DK578485A (es)
ES (4) ES8700850A1 (es)
HU (1) HUT40081A (es)
ZA (1) ZA859550B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (es) * 1986-04-11 1989-02-04 Hoechst India
DE3712369A1 (de) * 1987-04-11 1988-10-27 Bayer Ag Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
DE3712371A1 (de) * 1987-04-11 1988-10-27 Bayer Ag Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
DE3724909A1 (de) * 1987-07-28 1989-02-09 Bayer Ag Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
DE3833892A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3991589T1 (de) * 1989-02-17 1991-02-21 Inst Organicheskogo Sinteza Ak Basische salze der 2-(2,6-diemthyl-3,5-diaethoxykarboonyl-1,4-dihydropyridin-4-karboxamido)aethansulfonsaeure und verfahren zur herstellung derselben
WO1992006087A1 (en) * 1990-10-02 1992-04-16 Kaken Pharmaceutical Co., Ltd. Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
DE4118707A1 (de) * 1991-06-07 1992-12-10 Bayer Ag Pharmazeutische verwendung von 3-formyl-1,4-dihydropyridinen, neue verbindungen und verfahren zu ihrer herstellung
DE4202526A1 (de) * 1992-01-30 1993-08-05 Bayer Ag Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DK1252134T3 (da) * 2000-02-04 2005-01-31 Lonza Ag Fremgangsmåde til fremstilling af acetoacetylerede aromatiske aminer
CN1720243A (zh) * 2002-10-07 2006-01-11 瓦卡尔治疗公司 具有同时阻滞l-型钙通道和抑制3型磷酸二酯酶活性能力的二氢吡啶化合物
WO2018086703A1 (en) 2016-11-11 2018-05-17 Bayer Pharma Aktiengesellschaft Dihydropyridazinones substituted with phenylureas
EP3746079A1 (en) 2018-01-31 2020-12-09 Bayer Aktiengesellschaft Antibody drug conjugates (adcs) with nampt inhibitors
WO2021013693A1 (en) 2019-07-23 2021-01-28 Bayer Pharma Aktiengesellschaft Antibody drug conjugates (adcs) with nampt inhibitors
EP4252843A4 (en) * 2020-11-30 2025-02-19 Kyushu University, National University Corporation Compound having inhibitory action against excessive mitochondrial divisions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0107735B1 (en) * 1981-10-20 1988-10-19 Mitsui Toatsu Kagaku Kabushiki Kaisha Novel pyridazinone derivatives
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
AU5107085A (en) 1986-06-19
DK578485D0 (da) 1985-12-13
DE3576156D1 (de) 1990-04-05
ATE50571T1 (de) 1990-03-15
EP0185964B1 (de) 1990-02-28
DE3445852A1 (de) 1986-06-19
HUT40081A (en) 1986-11-28
ES556986A0 (es) 1987-12-16
ZA859550B (en) 1986-08-27
JPS61145180A (ja) 1986-07-02
US4707479A (en) 1987-11-17
ES556988A0 (es) 1987-12-16
ES8707501A1 (es) 1987-08-01
DK578485A (da) 1986-06-16
JPH0631224B2 (ja) 1994-04-27
CA1259996A (en) 1989-09-26
EP0185964A2 (de) 1986-07-02
ES8700850A1 (es) 1986-11-16
ES8801207A1 (es) 1987-12-16
ES556987A0 (es) 1987-08-01
ES8801208A1 (es) 1987-12-16
EP0185964A3 (en) 1986-12-03

Similar Documents

Publication Publication Date Title
ES549873A0 (es) 1,4-dihidropiridin-carboxiamidas.
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
DK162965C (da) Anvendelse af et difluornucleosid eller et farmaceutisk acceptabelt salt deraf til fremstilling af et laegemiddel til behandling af neoplasma
DK8987A (da) Lysstraaleklaede for medicinsk behandling
ES525692A0 (es) Procedimiento para la obtencion de dihidropirimidinas
ATE122232T1 (de) Melatoninderivate und kombinationen mit antiestrogenen zur behandlung von brustkarzinoma.
ES2059301T3 (es) Utilizacion de inhibidores de la enzima convertidora de angiotensina para el tratamiento de la aterosclerosis, trombosis y de la enfermedad vascular periferica.
SE8307146D0 (sv) 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger
DK221690D0 (da) Anvendelse af dimethylpolysiloxaner til behandling af sygdomme i det gastrointestinale omraade
NO164353C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner.
ES523264A0 (es) Procedimiento para la preparacion de 2-(3-piridil)-1,3,4-oxadiazoles
IT8720424A0 (it) Procedimento e macchina per il trattamento, in particolare la tintura discontinua, di tessuti in falde.
ES538403A0 (es) Procedimiento para la obtencion de antipodas opticos del (+7-1,7-difenil-3-metilaza-7-ciano-8-metil-nonano
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
KR880702036A (ko) 가죽류의 열처리를 위한, 특히 건조를 위한 설비
ES491921A0 (es) Procedimiento para preparar agentes para el tratamiento de fibras queratinicas
DE3467161D1 (de) Unsaturated arylalkyl ammonium salts
ES515142A0 (es) Procedimiento para el tratamiento alcali-seco de textiles de fibras celulosicas.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
FI873483A0 (fi) Oxiranpseudooligosackarider, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
NO884635D0 (no) Fremgangsmaate for behandling av most.
FR2416890A1 (fr) Derives de 1,5-benzothiazepines, leur preparation et leurs utilisations therapeutiques
IT8305229A0 (it) Procedimento per economizzare l'energia utilizzata nei trattamenti termici dei tessuti in pezza.
IT8049814A0 (it) Macchina e procedimento per la produzione il trattamento ed il finissaggio di tessuti
DE3774715D1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.